# The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men

> **NCT02303483** · NA · COMPLETED · sponsor: **Aarhus University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Obese

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA )
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02303483
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-04
- **Primary completion:** 2017-04-04
- **Final completion:** 2017-04-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303483, "The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02303483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*